15.03.2021 To the attention of interested persons EMA press release: EMA’s safety committee continues investigation of COVID-19 Vaccine AstraZeneca and […]

11.03.2021 To the attention of interested persons EMA press release: EMA recommends COVID-19 Vaccine Janssen for authorisation in the EU. […]

11.03.2021 To the attention of interested persons EMA press release: COVID-19 Vaccine Janssen (COVID-19 vaccine (Ad26.COV2-S [recombinant])). download document …

11.03.2021 To the attention of interested persons EMA press release: EMA starts rolling review of Eli Lilly antibodies bamlanivimab and […]

11.03.2021 To the attention of interested persons EMA press release: COVID-19 Vaccine AstraZeneca: PRAC preliminary view suggests no specific issue […]

11.03.2021 To the attention of interested persons EMA press release: Reflection paper on the regulatory requirements for vaccines intended to […]

04.03.2021 To the attention of interested persons EMA press release: EMA review of regdanvimab for COVID-19 to support national decisions […]

08.03.2021 To the attention of interested persons EMA press release: EMA issues advice on use of antibody combination (bamlanivimab / […]

04.03.2021 To the attention of interested persons EMA press release: EMA starts rolling review of the Sputnik V COVID-19 vaccine […]

04.03.2021 To the attention of interested persons The NAMMDR took note of the existence in the public space of some […]